APA (7th ed.) Citation

Ma, J., Lang, B., Wang, L., Zhou, Y., Fu, C., Tian, C., & Xue, L. (2025). Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas. Molecular Biotechnology, 67(6), 2286. https://doi.org/10.1007/s12033-024-01197-4

Chicago Style (17th ed.) Citation

Ma, Jinyang, Bojuan Lang, Lei Wang, Youdong Zhou, Changtao Fu, Chunlei Tian, and Lixin Xue. "Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas." Molecular Biotechnology 67, no. 6 (2025): 2286. https://doi.org/10.1007/s12033-024-01197-4.

MLA (9th ed.) Citation

Ma, Jinyang, et al. "Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas." Molecular Biotechnology, vol. 67, no. 6, 2025, p. 2286, https://doi.org/10.1007/s12033-024-01197-4.